Why the windtree therapeutics Stock raised so much in February?

The stock price of Windtree Therapeutics (WINT) experienced a significant increase of 20.44% on February 10, 2025. This rise can be attributed to **Positive Clinical Trial Update**. Windtree Therapeutics reported positive clinical trial updates for its lead product candidate, istaroxime. The company announced the initiation of a Phase III program for the treatment of acute decompensated heart failure and early cardiogenic shock. These updates likely contributed to the increased investor confidence and positive market sentiment, leading to the significant stock price increase. |code|Ticker|Name|Date|Percentage Change|market_code| |---|---|---|---|---|---| |WINT|WINT.O|Windtree|20250203|-3.8285|186| |WINT|WINT.O|Windtree|20250204|-4.7771|186| |WINT|WINT.O|Windtree|20250205|4.2642|186| |WINT|WINT.O|Windtree|20250206|-2.0048|186| |WINT|WINT.O|Windtree|20250207|-3.928|186| |WINT|WINT.O|Windtree|20250210|20.4429|186| |WINT|WINT.O|Windtree|20250211|13.1542|186| |WINT|WINT.O|Windtree|20250212|6.3125|186| |WINT|WINT.O|Windtree|20250213|-9.465|186| |WINT|WINT.O|Windtree|20250214|-10.7792|186|